Y-mAbs Therapeutics Inc. (YMAB)

AI Score

Unlock

4.08

-0.05 (-1.21%)

At close: Apr 25, 2025, 3:27 PM

Y-mAbs Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q1 2017
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Mar 31, 2017
Cash & Equivalents	67.23M	68.12M	77.81M	75.75M	78.64M	86.57M	87.91M	92.63M	105.76M	114.53M	133.66M	156.72M	181.56M	215.73M	233.59M	252.27M	114.63M	131.27M	158.06M	185.77M	207.14M	98.19M	120.16M	134.25M	147.84M	163.29M	70.15M	-90.48M	90.48M	-16.88M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	180.97M	n/a	33.75M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	18.26M	18.37M	13.46M	11.17M	12.49M	9.41M	12.25M	8.66M	5.68M	5.6M	5.75M	6.84M	3.17M	2.95M	2.99M	3.03M	3.29M	2.98M	357K	381K	370K	318K	244K	243K	187K	188K	1.45M	-90.48M	772K	-16.88M
Receivables	19.69M	19.92M	38.22M	20.59M	22.45M	18.87M	19.12M	18.7M	12.53M	9.25M	7.21M	9.32M	7.71M	7.26M	8.52M	6M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	7.21M	9.56M	8.5M	8.45M	5.07M	7.11M	5.19M	8.95M	6.7M	6.24M	6.79M	5.59M	5.51M	4.79M	3.82M	1M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	4.37M	1.46M	2.24M	3.48M	4.96M	2.3M	3.57M	3.73M	5.45M	3.23M	6.25M	6.1M	7.47M	2.8M	3.44M	4.74M	7.73M	1.94M	5.26M	4.06M	4.82M	1.4M	3.03M	2.79M	3.69M	2.75M	1.58M	n/a	872K	n/a
Total Current Assets	98.51M	99.06M	126.76M	108.27M	111.11M	114.86M	115.78M	124.01M	130.45M	133.24M	153.92M	177.74M	202.26M	230.58M	249.37M	264.01M	122.36M	133.21M	163.32M	189.84M	211.96M	99.59M	123.19M	137.03M	151.53M	166.04M	71.73M	90.48M	91.36M	16.88M
Property-Plant & Equipment	859K	1.13M	1.36M	1.33M	1.64M	1.89M	1.55M	1.88M	2.34M	3.54M	3.94M	4.85M	5.69M	4.65M	5.32M	6.07M	6.39M	7.01M	3.65M	3.86M	4.04M	3.77M	2.61M	2.72M	205K	162K	118K	n/a	n/a	n/a
Goodwill & Intangibles	2.28M	2.37M	2.45M	2.54M	2.63M	2.72M	2.81M	2.9M	2.99M	1.53M	1.57M	1.62M	1.66M	1.8M	1.8M	1.8M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	21.39M	21.86M	17.27M	15.05M	16.76M	14.02M	16.61M	13.44M	11.01M	10.67M	11.26M	13.31M	10.52M	9.4M	10.11M	10.91M	9.68M	9.99M	4.01M	4.24M	4.41M	4.09M	2.85M	2.96M	392K	350K	1.57M	-90.48M	772K	-16.88M
Total Assets	119.9M	120.92M	144.03M	123.31M	127.87M	128.88M	132.4M	137.44M	141.46M	143.91M	165.18M	191.05M	212.78M	239.98M	259.48M	274.92M	132.05M	143.19M	167.33M	194.07M	216.37M	103.68M	126.04M	140M	151.92M	166.39M	73.3M	n/a	92.13M	n/a
Account Payables	6.66M	7.88M	10.19M	6.73M	6.06M	7.61M	7.25M	8.84M	14.18M	13.72M	11.29M	14.66M	13.55M	11.02M	6.8M	6.54M	9.37M	10.32M	9.82M	10.26M	8.52M	7.63M	8.91M	5.91M	5.87M	6.83M	4.24M	n/a	5.91M	n/a
Deferred Revenue	n/a	n/a	n/a	-888K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.36M	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	630K	n/a	842K	n/a	902K	898K	829K	855K	n/a	1.2M	1.09M	1.45M	n/a	1.85M	n/a	1.97M	n/a	1.89M	569K	548K	n/a	516K	502K	517K	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	16.41M	16.64M	25.01M	4.37M	8.41M	9.6M	12.81M	11.23M	2.44M	11.82M	11.82M	9.36M	5.71M	6.59M	4.49M	3.52M	3.61M	1.97M	2.19M	1.91M	354K	3.57M	2.08M	543K	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	23.7M	25.29M	43.47M	17.61M	20.13M	21.81M	24.23M	25.92M	28.28M	32.02M	29.45M	29.04M	27.88M	25.36M	20.99M	17M	19.54M	19.78M	15.71M	14.84M	13.59M	13.99M	13.63M	10.3M	9.12M	9.32M	5.73M	n/a	7.92M	n/a
Long-Term Debt	190K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	4.01M	2.9M	4.8M	6.23M	6.24M	6.2M	3.07M	3.07M	3.05M	2.98M	3.03M	2.94M	2.95M	3.12M	3.19M	4.18M	4.66M	4.39M	4.21M	2.36M	2.16M	1.93M	2.05M	2.05M	2.27M	2.05M	2.05M	n/a	2.05M	n/a
Total Long-Term Liabilities	4.2M	3.2M	5.23M	6.52M	6.76M	6.92M	3.48M	3.7M	3.95M	4M	4.33M	4.53M	4.8M	3.77M	4.18M	5.7M	6.68M	6.91M	5.61M	3.9M	3.88M	3.75M	4.03M	4.18M	2.27M	2.05M	2.05M	n/a	2.05M	n/a
Total Liabilities	27.9M	28.49M	48.7M	24.13M	26.88M	28.73M	27.71M	29.62M	32.23M	36.02M	33.78M	33.58M	32.68M	29.13M	25.16M	22.7M	26.21M	26.68M	21.32M	18.74M	17.46M	17.75M	17.66M	14.48M	11.4M	11.37M	7.78M	n/a	9.97M	n/a
Total Debt	820K	1.07M	1.27M	1.18M	1.42M	1.62M	1.25M	1.48M	1.77M	2.22M	2.39M	3.05M	3.63M	2.5M	3M	3.49M	3.98M	4.4M	1.97M	2.09M	2.23M	2.34M	2.48M	2.65M	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	4K	4K	4K	4K	4K	4K	4K	4K	4K	4K	4K	4K	4K	4K	4K	4K	4K	4K	4K	4K	4K	3K	3K	3K	3K	3K	3K	n/a	3K	n/a
Retained Earnings	-487.14M	-480.35M	-473.35M	-464.1M	-457.47M	-456.48M	-448.74M	-442.43M	-436.04M	-437.2M	-409.67M	-368.54M	-340.48M	-303.58M	-274.72M	-251.79M	-285.2M	-265.27M	-232.44M	-192.04M	-165.86M	-142.73M	-118.81M	-100.77M	-84.83M	-70.78M	-59.35M	n/a	-41.56M	n/a
Comprehensive Income	2.26M	-36K	1.05M	848K	449K	1.85M	1.04M	1.02M	1.33M	4.7M	3.1M	1.68M	1.37M	225K	-13K	-91K	-526K	-28K	-16K	75K	50K	131K	-3K	63K	7K	-48K	-88K	82.15M	-169K	12.06M
Shareholders Equity	92M	92.43M	95.34M	99.19M	100.98M	100.15M	104.68M	107.83M	109.22M	107.9M	131.4M	157.47M	180.11M	210.84M	234.32M	252.22M	105.84M	116.51M	146.01M	175.33M	198.9M	85.94M	108.38M	125.51M	140.53M	155.03M	65.52M	82.15M	82.15M	12.06M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	180.97M	n/a	33.75M